Agency Agreements in the Biotechnology Industry
282 Contracts & Agreements
- AbbVie Inc. (2 contracts)
- ACHIEVE LIFE SCIENCES, INC. (1)
- Adhera Therapeutics, Inc. (1)
- ADiTx Therapeutics, Inc. (1)
- ADMA BIOLOGICS, INC. (1)
- ALBIREO PHARMA, INC. (2)
- Allarity Therapeutics, Inc. (3)
- Altimmune, Inc. (4)
- AMICUS THERAPEUTICS, INC. (1)
- AmpliPhi Biosciences Corp (1)
- Anixa Biosciences Inc (1)
- Aprea Therapeutics, Inc. (1)
- Aptevo Therapeutics Inc. (5)
- Aptose Biosciences Inc. (2)
- ARCA biopharma, Inc. (5)
- ASSEMBLY BIOSCIENCES, INC. (1)
- ATHERSYS, INC (5)
- ATOSSA GENETICS INC (3)
- Avid Bioservices, Inc. (1)
- AZIYO BIOLOGICS, INC. (1)
- AzurRx BioPharma, Inc. (5)
- Benitec Biopharma Inc. (2)
- BIO-PATH HOLDINGS INC (5)
- bioAffinity Technologies, Inc. (3)
- BioCardia, Inc. (4)
- BIOCEPT INC (6)
- BIOCRYST PHARMACEUTICALS INC (1)
- BioRestorative Therapies, Inc. (1)
- BRAINSTORM CELL THERAPEUTICS INC. (3)
- BriaCell Therapeutics Corp. (3)
- BullFrog AI Holdings, Inc. (1)
- Calyxt, Inc. (1)
- CAPRICOR THERAPEUTICS, INC. (1)
- CEL SCI CORP (2)
- Cellectar Biosciences, Inc. (3)
- Celsion CORP (3)
- Chardan Healthcare Acquisition Corp. (1)
- Chelsea Worldwide Inc. (1)
- Cidara Therapeutics, Inc. (1)
- CLEVELAND BIOLABS INC (2)
- CohBar, Inc. (1)
- CONTRAFECT Corp (2)
- Corbus Pharmaceuticals Holdings, Inc. (1)
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (1)
- CTD HOLDINGS INC (1)
- Cyclacel Pharmaceuticals, Inc. (4)
- DelMar Pharmaceuticals, Inc. (4)
- Diffusion Pharmaceuticals Inc. (2)
- Emerald Bioscience, Inc. (1)
- Enochian Biosciences Inc (4)
- Fortress Biotech, Inc. (2)
- GALECTIN THERAPEUTICS INC (1)
- Galera Therapeutics, Inc. (1)
- Gene Biotherapeutics, Inc. (2)
- Genprex, Inc. (4)
- GeoVax Labs, Inc. (3)
- GT Biopharma, Inc. (1)
- GX Acquisition Corp. (3)
- HCW Biologics Inc. (1)
- HEAT BIOLOGICS, INC. (1)
- HEMISPHERX BIOPHARMA INC (1)
- iBio, Inc. (2)
- Inhibikase Therapeutics, Inc. (3)
- InMed Pharmaceuticals Inc. (1)
- Inmune Bio, Inc. (4)
- INSMED Inc (1)
- International Stem Cell CORP (1)
- Isoray, Inc. (2)
- KBL MERGER CORP. IV (2)
- LEAP THERAPEUTICS, INC. (1)
- LEXICON PHARMACEUTICALS, INC. (1)
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
- LONGEVERON LLC (1)
- MARIZYME INC (3)
- Marker Therapeutics, Inc. (2)
- MATEON THERAPEUTICS INC (3)
- Matinas BioPharma Holdings, Inc. (3)
- Moleculin Biotech, Inc. (4)
- Momenta Pharmaceuticals, Inc. (1)
- NANOVIRICIDES, INC. (1)
- NantKwest, Inc. (3)
- NEUROTROPE BIOSCIENCE, INC. (1)
- Neurotrope, Inc. (1)
- NEWLINK GENETICS CORP (2)
- NORTHWEST BIOTHERAPEUTICS INC (1)
- NTN BUZZTIME INC (1)
- Ohr Pharmaceutical Inc (1)
- OncBioMune Pharmaceuticals, Inc (1)
- ONCOSEC MEDICAL Inc (2)
- ORAGENICS INC (3)
- ORGANOVO HOLDINGS, INC. (3)
- Orgenesis Inc. (1)
- Petra Acquisition Inc. (9)
- Phio Pharmaceuticals Corp. (1)
- PLURISTEM THERAPEUTICS INC (1)
- POLARITYTE, INC. (2)
- Propanc Biopharma, Inc. (1)
- Q BioMed Inc. (1)
- REGENERX BIOPHARMACEUTICALS INC (1)
- RenovoRx, Inc. (1)
- REXAHN PHARMACEUTICALS, INC. (2)
- Rezolute, Inc. (1)
- RITTER PHARMACEUTICALS INC (10)
- SANGAMO THERAPEUTICS, INC (1)
- Sarepta Therapeutics, Inc. (2)
- Scholar Rock Holding Corp (1)
- SELLAS Life Sciences Group, Inc. (3)
- Seres Therapeutics, Inc. (1)
- Shuttle Pharmaceuticals Holdings, Inc. (3)
- SOLENO THERAPEUTICS INC (1)
- SOLIGENIX, INC. (6)
- SOPHIRIS BIO INC. (1)
- SPHERIX INC (2)
- Sun BioPharma, Inc. (8)
- SYNLOGIC, INC. (1)
- Synthetic Biologics, Inc. (3)
- T2 Biosystems, Inc. (1)
- TENAX THERAPEUTICS, INC. (9)
- Tonix Pharmaceuticals Holding Corp. (7)
- Transcode Therapeutics, Inc. (1)
- Trovagene, Inc. (1)
- Unicycive Therapeutics, Inc. (1)
- VACCINEX, INC. (1)
- VistaGen Therapeutics, Inc. (1)
- VITAL THERAPIES INC (1)
- WINDTREE THERAPEUTICS INC (1)
- YIELD10 BIOSCIENCE, INC. (4)
- ZIOPHARM ONCOLOGY INC (2)
- Placement Agency Agreement dated December 29. 2024, by and between CEL-SCI Corporation and ThinkEquity, LLC (CEL SCI CORP, Filed With SEC on December 31, 2024)
- Placement Agency Agreement by and between the Company and Maxim Group LLC, dated December 27, 2024 (KBL MERGER CORP. IV, Filed With SEC on December 30, 2024)
- Placement Agency Agreement, dated as of November 21, 2024, by and among Aptose Biosciencs Inc. and A.G.P./Alliance Global Partners, as placement agent (Aptose Biosciences Inc., Filed With SEC on November 25, 2024)
- Placement Agency Agreement, dated November 18, 2024, between the Company and Maxim Group LLC (HCW Biologics Inc., Filed With SEC on November 20, 2024)
- Placement Agency Agreement, dated as of October 29, 2024, by and among Shuttle Pharmaceuticals Holdings, Inc. and A.G.P./Alliance Global Partners and Boustead Securities, LLC, as... (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on November 1, 2024)
- Form of Placement Agency Agreement (LIXTE BIOTECHNOLOGY HOLDINGS, INC., Filed With SEC on November 1, 2024)
- Form of Placement Agency Agreement (Aptose Biosciences Inc., Filed With SEC on October 31, 2024)
- Form of Placement Agency Agreement (RITTER PHARMACEUTICALS INC, Filed With SEC on October 24, 2024)
- Placement Agency Agreement dated October 22, 2024 between Creative Medical Technology Holdings, Inc. and Roth Capital Partners (CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC., Filed With SEC on October 23, 2024)
- Form of Placement Agency Agreement (BullFrog AI Holdings, Inc., Filed With SEC on October 21, 2024)
- Placement Agency Agreement, dated October 18, 2024, by and between bioAffinity Technologies Inc. and WallachBeth Capital LLC (bioAffinity Technologies, Inc., Filed With SEC on October 21, 2024)
- Form of Placement Agency Agreement (Shuttle Pharmaceuticals Holdings, Inc., Filed With SEC on October 18, 2024)
- Placement Agency Agreement, dated as of October 1, 2024, by and between BriaCell Therapeutics Corp. and ThinkEquity LLC (BriaCell Therapeutics Corp., Filed With SEC on October 2, 2024)
- Placement Agency Agreement, dated September 30, 2024, by and between the Company and Maxim Group LLC (HEMISPHERX BIOPHARMA INC, Filed With SEC on October 1, 2024)
- Placement Agency Agreement, dated as of September 26, 2024, by and between Theriva Biologics, Inc. and A.G.P./Alliance Global Partners, as placement agent (Synthetic Biologics, Inc., Filed With SEC on September 30, 2024)
- Placement Agency Agreement, dated September 30, 2024, by and between Clene Inc. and Canaccord Genuity LLC (Chelsea Worldwide Inc., Filed With SEC on September 30, 2024)
- Placement Agency Agreement, dated September 16, 2024, between the Company and Roth Capital Partners (Aptevo Therapeutics Inc., Filed With SEC on September 18, 2024)
- Form of Placement Agency Agreement (Inmune Bio, Inc., Filed With SEC on September 16, 2024)
- Placement Agency Agreement (BriaCell Therapeutics Corp., Filed With SEC on September 12, 2024)
- Form of Placement Agency Agreement (Synthetic Biologics, Inc., Filed With SEC on September 10, 2024)
- Placement Agency Agreement dated, September 4, 2024, between Oragenics, Inc. and Dawson James Securities, Inc (ORAGENICS INC, Filed With SEC on September 5, 2024)
- Placement Agency Agreement dated August 29, 2024, between BioCardia, Inc. and A.G.P./Alliance Global Partners (BioCardia, Inc., Filed With SEC on September 3, 2024)
- Form of Placement Agency Agreement (GeoVax Labs, Inc., Filed With SEC on August 30, 2024)
- PLACEMENT AGENCY AGREEMENT (Aptevo Therapeutics Inc., Filed With SEC on August 30, 2024)
- Form of Placement Agency Agreement (BioCardia, Inc., Filed With SEC on August 29, 2024)
- Form of Placement Agency Agreement (RITTER PHARMACEUTICALS INC, Filed With SEC on August 22, 2024)
- Form of Placement Agency Agreement (GeoVax Labs, Inc., Filed With SEC on August 21, 2024)
- Form of Placement Agency Agreement (RITTER PHARMACEUTICALS INC, Filed With SEC on August 9, 2024)
- Form of Placement Agency Agreement (RITTER PHARMACEUTICALS INC, Filed With SEC on August 7, 2024)
- Placement Agency Agreement, dated August 2, 2024, by and between bioAffinity Technologies Inc. and WallachBeth Capital LLC (bioAffinity Technologies, Inc., Filed With SEC on August 5, 2024)
- Placement Agency Agreement dated July 26. 2024, by and between CEL-SCI Corporation and ThinkEquity, LLC (CEL SCI CORP, Filed With SEC on July 29, 2024)
- Form of Placement Agency Agreement (Transcode Therapeutics, Inc., Filed With SEC on July 24, 2024)
- Form of Placement Agency Agreement (GeoVax Labs, Inc., Filed With SEC on July 12, 2024)
- Placement Agency Agreement, dated July 9, 2024, between Tonix Pharmaceuticals Holding Corp. and Dawson James Securities Inc (Tonix Pharmaceuticals Holding Corp., Filed With SEC on July 10, 2024)
- Placement Agency Agreement dated June 28, 2024, between the Company and Roth Capital Partners (Aptevo Therapeutics Inc., Filed With SEC on July 1, 2024)
- Placement Agency Agreement, dated June 27, 2024, between Tonix Pharmaceuticals Holding Corp. and Dawson James Securities Inc (Tonix Pharmaceuticals Holding Corp., Filed With SEC on June 28, 2024)
- Placement Agency Agreement, dated as of June 27, 2024 by and between the Company and the placement agent party thereto (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on June 28, 2024)
- Placement Agency Agreement dated June 25, 2024 between Oragenics, Inc. and Dawson James Securities, Inc (ORAGENICS INC, Filed With SEC on June 26, 2024)
- Placement Agency Agreement (AZIYO BIOLOGICS, INC., Filed With SEC on June 18, 2024)
- Form of Placement Agency Agreement (Aptevo Therapeutics Inc., Filed With SEC on June 14, 2024)
